Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Small Cap
RPG Life Sciences Ltd.
₹2,110.10
Invest in RPGLIFE with up to 2.50x margin.
Trade with MTF₹2081.70
₹2119.50
₹1733.00
₹2725.00
Markets Today
Historical Performance
As of 09-06-2026 22:59, RPG Life Sciences Ltd. share price today is ₹0, with a change of ₹-2089.00 (-100.00%) from the previous close of ₹2089. The stock opened at ₹2089 and traded between ₹2081.7 and ₹2119.5, with a total traded volume of 3798 shares. The company has a market capitalization of ₹3501.5 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2725 and ₹1733, respectively.
RPG Life Sciences Ltd. valuation metrics include a P/E ratio of 30.4, EPS of ₹69.64, and book value of ₹18.90. Profitability indicators show ROE of 19.02% along with a dividend yield of 1.1%. RPG Life Sciences Ltd. has reported revenue of ₹707.52 Cr and net profit of ₹115.17 Cr.
RPG Life Sciences Ltd. technical indicators include Day RSI at 38.65, Day MFI at 24.41, Day ADX at 22.54. Additional indicators include Commodity Channel Index (CCI) at -150.5 and Williams %R at -91.82. Momentum indicators show Day MACD at -5.9, Day MACD Signal Line at 23.55, DayATR at 85.17. Rate of Change indicators for RPG Life Sciences Ltd. include ROC125 at -5.69 and ROC21 at -16.17.
Exponential moving averages include EMA5 at ₹2150.2, EMA10 at ₹2184.8, EMA12 at ₹2193.9, EMA20 at ₹2206.2, EMA26 at ₹2199.8, EMA50 at ₹2155.7, EMA100 at ₹2133.6, EMA200 at ₹2158. Simple moving averages include SMA5 at ₹2160.1, SMA10 at ₹2189.8, SMA20 at ₹2252.4, SMA30 at ₹2251.2, SMA50 at ₹2113, SMA100 at ₹2061.8, SMA150 at ₹2147, SMA200 at ₹2194.5.
Support levels for RPG Life Sciences are placed at First Support ₹2036.30, Second Support ₹1983.60, Third Support ₹1901.90. Resistance levels are seen at First Resistance ₹2170.70, Second Resistance ₹2252.40, Third Resistance ₹2305.10. RPG Life Sciences Ltd. shareholding pattern shows promoter holding at 72.95%, FII holding at 0.87%, DII holding at 0%, public holding at 18.72%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 176.89 | 180.03 | 181.68 | 168.92 | 143.09 |
| Operating Expense | 144.02 | 140.27 | 142.65 | 133.45 | 117.60 |
| Operating Profit | 32.87 | 39.76 | 39.03 | 35.47 | 25.49 |
| Depreciation | 5.74 | 5.38 | 5.22 | 5.14 | 5.37 |
| Interest | 0.39 | 0.25 | 0.12 | 0.13 | 0.18 |
| Tax | 10.30 | 6.99 | 12.60 | 9.14 | 17.55 |
| Net Profit | 29.90 | 22.13 | 36.85 | 26.29 | 117.35 |
₹2110.10
↗ Bullish Moving Average
2
↘ Bearish Moving Average
14
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 73 | 73 | 73 | 73 | 73 | 73 |
| FII | 1.3 | 1.5 | 1.4 | 1.1 | 1 | 0.9 |
| DII | 6.1 | 6.1 | 6.4 | 6.7 | 7 | 7.4 |
| Public | 19.7 | 19.5 | 19.2 | 19.2 | 19 | 18.7 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 5.3 K | 12.34 K | 42.98% |
| Week | 5.07 K | 9.11 K | 55.71% |
| 1 Month | 4.47 K | 8.52 K | 52.48% |
| 6 Month | 7.71 K | 28.59 K | 26.97% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Expensive Performers (DVM)
Dividend yield greater than sector dividend yield
Growth in Net Profit with increasing Profit Margin (QoQ)
Companies with Low Debt
Companies with Zero Promoter Pledge
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 27 Jun, 2025 | 4 | SPECIAL | 27 Jun, 2025 | Equity Share |
| 27 Jun, 2025 | 20 | FINAL | 27 Jun, 2025 | Equity Share |
| 28 Jun, 2024 | 16 | FINAL | 28 Jun, 2024 | Equity Share |
| 21 Jul, 2023 | 12 | FINAL | 21 Jul, 2023 | Equity Share |
| 14 Jul, 2022 | 9.6 | FINAL | 15 Jul, 2022 | Equity Share |
| 13 Aug, 2021 | 7.2 | FINAL | 17 Aug, 2021 | Equity Share |
| 24 Mar, 2020 | 4 | INTERIM | 26 Mar, 2020 | Equity Share |
| 22 Jul, 2019 | 2.4 | FINAL | Equity Share | |
| 19 Jul, 2018 | 2.4 | FINAL | Equity Share | |
| 13 Jul, 2017 | 2.8 | FINAL | Equity Share |
Financials | |||||
|---|---|---|---|---|---|
| Price (₹) | ₹558.75 | ₹6.16 | ₹136.48 | ₹15.10 | ₹69 |
| % Change | 1.42% | -1.12% | 4.30% | 7.40% | 3.51% |
| Revenue TTM (₹ Cr) | - | ₹83.60 | ₹287.68 | ₹176.50 | ₹85.74 |
| Net Profit TTM (₹ Cr) | - | ₹-34.95 | ₹14.88 | ₹27.81 | ₹24.58 |
| PE TTM | - | -1.50 | 35.40 | 28.90 | 8.20 |
| 1 Year Return | 42.87 | 515 | 7.51 | 66.37 | -48.66 |
| ROCE | 3.56 | -5.63 | - | 17.36 | 5.25 |
Bafna Pharmaceuticals Ltd.
₹ 174.58
-10.00%
Alpa Laboratories Ltd.
₹ 69.80
+2.29%
SMS Pharmaceuticals Ltd.
₹ 380.00
+3.04%
Nectar Lifesciences Ltd.
₹ 11.60
-0.34%
Mangalam Drugs and Organics Ltd.
₹ 28.40
-0.18%
Indoco Remedies Ltd.
₹ 207.00
+3.74%
Ind-Swift Laboratories Ltd.
₹ 163.70
+4.44%
Lincoln Pharmaceuticals Ltd.
₹ 635.50
+2.53%
Panacea Biotec Ltd.
₹ 612.00
+10.69%
Medicamen Biotech Ltd.
₹ 241.00
+7.83%
Themis Medicare Ltd.
₹ 106.90
+3.12%
Venus Remedies Ltd.
₹ 1610.70
-5.00%
Bal Pharma Ltd.
₹ 87.06
+2.38%
Hikal Ltd.
₹ 181.69
+1.06%
NGL Fine - Chem Ltd.
₹ 2830.00
+6.66%
Hester Biosciences Ltd.
₹ 1920.00
-2.20%
Natural Capsules Ltd.
₹ 156.00
-1.20%
Krebs Biochemicals & Industries Ltd.
₹ 67.68
+0.79%
Kilitch Drugs(I) Ltd.
₹ 188.80
+12.97%
Syncom Formulation (India) Ltd.
₹ 14.60
+3.18%
Aarey Drugs & Pharmaceuticals Ltd.
₹ 80.00
+0.11%
Biofil Chemicals & Pharmaceuticals Ltd.
₹ 36.05
+2.12%
Aarti Drugs Ltd.
₹ 374.05
+2.19%
Wanbury Ltd.
₹ 266.00
+5.39%
Orchid Pharma Ltd.
₹ 862.00
+2.31%
By signing up I certify terms, conditions & privacy policy